Headline News about Ionis Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2023/CathieWood_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/27/ions.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Analyst Expectations for Ionis Pharmaceuticals's Future
September 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Ionis Pharmaceuticals's Future
June 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Ionis Pharmaceuticals Q1 Earnings
May 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/26/syringe-5904302_12802.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/ions.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/05/Stock-IonisHQ-01-company.jpg)
![](https://investorplace.com/wp-content/uploads/2020/06/death-stocks-to-sell.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/07/alny.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Ionis Pharmaceuticals's Earnings Outlook
May 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/31/ions.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/31/apple_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/04/stock-drugs-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/03/biib.png?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Via Talk Markets
![](https://www.investors.com/wp-content/uploads/2022/10/Stock-vervetherapeutics-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/12/ntla.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/07/ions.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/07/dna-g47ecea8df_1280.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/26/biib.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/25/analysis-gc071ae9e3_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/25/biib.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/02/cancer.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.